William Blair & Company’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
12,295
+3,140
| +34% | +$276K | ﹤0.01% | 877 |
|
|
2025
Q1 | $834K | Sell |
9,155
-76
| -0.8% | -$6.93K | ﹤0.01% | 937 |
|
|
2024
Q4 | $796K | Buy |
9,231
+106
| +1% | +$9.15K | ﹤0.01% | 969 |
|
|
2024
Q3 | $867K | Buy |
9,125
+2,184
| +31% | +$208K | ﹤0.01% | 944 |
|
|
2024
Q2 | $635K | Buy |
6,941
+924
| +15% | +$84.5K | ﹤0.01% | 1027 |
|
|
2024
Q1 | $546K | Buy |
6,017
+2,894
| +93% | +$262K | ﹤0.01% | 1062 |
|
|
2023
Q4 | $254K | Sell |
3,123
-465
| -13% | -$37.8K | ﹤0.01% | 1316 |
|
|
2023
Q3 | $287K | Buy |
3,588
+2,706
| +307% | +$216K | ﹤0.01% | 1254 |
|
|
2023
Q2 | $69.5K | Hold |
882
| – | – | ﹤0.01% | 1554 |
|
|
2023
Q1 | $68.5K | Hold |
882
| – | – | ﹤0.01% | 1547 |
|
|
2022
Q4 | $68.6K | Buy |
882
+682
| +341% | +$53K | ﹤0.01% | 1534 |
|
|
2022
Q3 | $13K | Hold |
200
| – | – | ﹤0.01% | 1726 |
|
|
2022
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 1750 |
|
|
2022
Q1 | $16K | Hold |
200
| – | – | ﹤0.01% | 1809 |
|
|
2021
Q4 | $15K | Buy |
+200
| New | +$15K | ﹤0.01% | 1873 |
|
|
2020
Q2 | – | Sell |
-90
| Closed | -$5K | – | 1729 |
|
|
2020
Q1 | $5K | Hold |
90
| – | – | ﹤0.01% | 1591 |
|
|
2019
Q4 | $6K | Hold |
90
| – | – | ﹤0.01% | 1658 |
|
|
2019
Q3 | $5K | Sell |
90
-45
| -33% | -$2.5K | ﹤0.01% | 1639 |
|
|
2019
Q2 | $8K | Sell |
135
-89
| -40% | -$5.27K | ﹤0.01% | 1656 |
|
|
2019
Q1 | $14K | Buy |
224
+179
| +398% | +$11.2K | ﹤0.01% | 1601 |
|
|
2018
Q4 | $2K | Sell |
45
-150
| -77% | -$6.67K | ﹤0.01% | 1632 |
|
|
2018
Q3 | $13K | Hold |
195
| – | – | ﹤0.01% | 1545 |
|
|
2018
Q2 | $12K | Hold |
195
| – | – | ﹤0.01% | 1509 |
|
|
2018
Q1 | $11K | Buy |
+195
| New | +$11K | ﹤0.01% | 1440 |
|